在儿科神经胃肠病学中新的药理疗法
Alex Cohen1, Justin C Wheeler2
1Department of Pediatrics, University of Utah, 81 North Mario Capecchi Drive, #1A.011, Salt Lake City, UT 84113, USA.
Gastroenterology clinics of North America
|August 2, 2025
概括
儿科神经胃肠病学正在出现新的药物,针对肠-大脑相互作用障碍 (DGBI) 和动力障碍. 这些已被批准用于成人的治疗方法为改善儿科肠道健康管理提供了希望.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 神经胃肠病学 神经胃肠病学
- 肠-大脑相互作用障碍 肠-大脑相互作用障碍
背景情况:
- 儿科神经胃肠病学针对儿童的肠道神经系统疾病.
- 肠-大脑相互作用障碍 (DGBI) 和动力障碍是重点关注的关键领域.
- 成人DGBI治疗的最新进展为儿科应用提供了潜力.
研究的目的:
- 审查最近对DGBI和动力障碍的药物治疗的进展.
- 要突出已批准或在成年人中显示有前途的治疗方法.
- 为了告知神经胃肠病学中潜在的儿科应用.
主要方法:
- 对治疗DGBI和动力障碍的药物的文献综述.
- 按机制和治疗条件对药物的分类.
- 专注于自2015年以来批准或研究的治疗方法.
主要成果:
- 分泌剂,血清激素激动剂和通道对抗剂用于便秘/IBS-C.
- 抗生素和阿片类抗激素治疗腹 (IBS-D) 的刺激性肠综合征.
- 功能性腹痛中的大麻素激动剂和恶心/循环吐综合征中的神经激素-1对抗剂.
结论:
- 几种药物类别显示在成人DGBI和动力障碍方面具有有效性.
- 这些成年人批准的治疗方法代表了儿科神经胃肠病学的潜在治疗途径.
- 需要进一步的研究来确定儿科的安全性和疗效.
相关概念视频
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
617
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
617
Inflammatory Bowel Disease IV: Pharmacological Management
190
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
190
Gastrointestinal Motility Disorders
596
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
596
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
260
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
260
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
402
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
402
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
318
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
318


